Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.
Press releases published on August 8, 2025

Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
Daniel Chao, M.D., Ph.D., joins Surrozen as Vice President of Clinical Development Surrozen forms Clinical Advisory Board comprised of leading retinal specialists Data Presentations at Association for Research in Vision and Ophthalmology Annual Meeting and …

Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant – – Vepdegestrant is the first PROteolysis TArgeting Chimera ( …

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options …

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatment Significant regulatory and pipeline advancements achieved …

Commerce to Present at Upcoming Investor Conference
AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver …

Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders
ATHENS, Greece, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Capital Clean Energy Carriers Corp. (NASDAQ: CCEC) (the “Corporation” or “CCEC”) has called an annual meeting of shareholders to be held at the Corporation’s headquarters in Greece …

Phunware Reports Second Quarter 2025 Financial Results
Delivers Strong First Half with Key Product Milestones and Customer Momentum Strong Liquidity Powering New Technology Improvements, AI Integration and Corporate Initiatives AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (“Phunware” or the …

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hyperion Defi, Inc. (NASDAQ: HYPD), the first U.S. public company to build a strategic treasury around the HYPE token and a pioneer in integrating decentralized finance with traditional corporate treasury …

Amwell makes grant to new employees under inducement plan
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its Class A common stock to two new …

NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
TORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced that an independent study showed that exosomes produced by NurExone outperformed a …

Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended …

IPG Chicago Facility Achieves TRUE Gold Zero Waste Certification
SARASOTA, Fla., Aug. 08, 2025 (GLOBE NEWSWIRE) -- IPG (“the Company”), a global provider of packaging and protective solutions, announced that its manufacturing facility in Chicago, IL, has been awarded GOLD certification under the TRUE (Total Resource Use …

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …

Outdoor Holding Company Reports First Quarter Fiscal 2026 Financial Results
SCOTTSDALE, Ariz., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Outdoor Holding Company (Nasdaq: POWW, POWWP) (“OHC,” “we,” “us,” “our” or the “Company”), the owner of GunBroker.com, the largest online marketplace for firearms, hunting and related products, today …

Secret DUO Now Available at South Jersey Skin Care
MOUNT LAUREL, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- South Jersey Skin Care …

USX Cyber® Launches Integrated Application Control Module in GUARDIENT® Platform
VIENNA, Va., Aug. 08, 2025 (GLOBE NEWSWIRE) -- USX Cyber®, a leading innovator in cybersecurity and compliance automation, proudly announces the release of its new in-house Application Control module—a powerful enhancement to its flagship GUARDIENT® …

Saputo Announces Election of Directors
MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (Saputo or the Company) announces that the nominees listed in the management information circular dated June 5, 2025, were elected as directors of Saputo at the annual meeting of …

Saputo annonce l’élection des administrateurs
MONTRÉAL, 08 août 2025 (GLOBE NEWSWIRE) -- Saputo inc. (TSX : SAP) (Saputo ou la Société) annonce que les candidats figurant dans la circulaire de sollicitation de procurations de la direction datée du 5 juin 2025 ont été élus administrateurs de Saputo …

U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
This press release is not intended for UK media. HERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 75% (N=71), as demonstrated in the Beamion-LUNG 1 clinical trial1 Accelerated approval follows Priority Review and …

Nang Robot Expands Product Line With New 3.3 Litre Tanks With Delivery Across Melbourne
Melbourne, Victoria , Aug. 08, 2025 (GLOBE NEWSWIRE) -- Nang Robot, Melbourne's leading service, is thrilled to announce the addition of 3.3Litre / 2.1kg (net) tanks to its product lineup. This expansion is set to enhance the company's already impressive …